Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
Clinical trial NCT06501183 · UNKNOWN
Trial details
- NCT number
- NCT06501183
- Sponsor
- Shanghai Pudong Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2025-05-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.